| Issue Date | Title | Author(s) |
| 2020-11 | Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial. | Wang, N; Salam, A; Webster, R; de Silva, A; Guggilla, R; Stepien, S; Mysore, J; Billot, L; Jan, S; Maulik, PK; Naik, N; Selak, V; Thom, S; Prabhakaran, D; Patel, A; Rodgers, A; TRIUMPH Study Group |
| 2022-05-17 | Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. | Lv, J; Wong, MG; Hladunewich, MA; Jha, V; Hooi, LS; Monaghan, H; Zhao, M; Barbour, S; Jardine, MJ; Reich, HN; Cattran, D; Glassock, R; Levin, A; Wheeler, DC; Woodward, M; Billot, L; Stepien, S; Rogers, K; Chan, TM; Liu, Z-H; Johnson, DW; Cass, A; Feehally, J; Floege, J; Remuzzi, G; Wu, Y; Agarwal, R; Zhang, H; Perkovic, V; TESTING Study Group, |
| 2019-10-01 | Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial | Lung, T; Jan, S; de Silva, HA; Guggilla, R; Maulik, PK; Naik, N; Patel, A; de Silva, AP; Rajapakse, S; Ranasinghe, G; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Stepien, S; Thom, S; Webster, R; Lea-Laba, T |
| 2019-01-01 | Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-Analysis of randomised clinical trials | Selak, V; Webster, R; Stepien, S; Bullen, C; Patel, A; Thom, S; Arroll, B; Bots, ML; Brown, A; Crengle, S; Dorairaj, P; Elley, CR; Grobbee, DE; Harwood, M; Hillis, GS; Laba, TL; Neal, B; Peiris, D; Rafter, N; Reid, C; Stanton, A; Tonkin, A; Usherwood, T; Wadham, A; Rodgers, A |
